- Home
- Labeler Index
- Alexion Pharmaceuticals Inc.
- 25682-028
- NDC Crossover: 25682-028 Ultomiris
NDC Crossover 25682-028 Ultomiris
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Ravulizumab
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 25682-028 – Ultomiris, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Ultomiris
- OR Generic name: Ravulizumab
- AND the same Administration Route: intravenous
- OR Dosage Form: solution, concentrate
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 25682-022 | Ultomiris | Ravulizumab | Solution, Concentrate | Intravenous | Alexion Pharmaceuticals Inc. | Human Prescription Drug |
| 25682-025 | Ultomiris | Ravulizumab | Solution, Concentrate | Intravenous | Alexion Pharmaceuticals Inc. | Human Prescription Drug |
